Review of corruption in the health sector: Theory, methods and interventions

Health Policy and Planning

Volumn 23, Issue 2, 2008, Pages 83-94

  Vian, Taryn ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Accountability; Corruption; Developing countries; Health care management; Health policy; Informal payments; International health; Transparency

Indexed keywords

CORRUPTION; DEVELOPING COUNTRY; DRUG INDUSTRY; FINANCIAL MANAGEMENT; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HOUSEHOLD; INFORMATION PROCESSING; PUBLIC HEALTH; REVIEW; SOCIOPATHY;

DATA COLLECTION; FRAUD; HEALTH CARE SECTOR; HUMANS; MODELS, THEORETICAL; POLICY MAKING; UNITED STATES;

EID: 39749121452     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czm048     Document Type: Review

References (77)

1. Alcazar L, Andrade R. 2001. Induced demand and absenteeism in Peruvian hospitals. In: Di Tella R, Savedoff WD, (eds). Diagnosis corruption: fraud in Latin America's public hospitals. Washington, DC: Inter-American Development Bank.
2. Allin S, Davaki K, Mossialos E. 2006. Paying for 'free' health care: the conundrum of informal payments in post-communist Europe. In: Transparency International. Global Corruption Report 2006: Special focus on corruption and health. London: Pluto Press, pp. 62-71.
3. Anderson T. 2006. Outlook: Anti-corruption plan aims to slash drug prices. The Guardian Weekly 28.
4. Azfar O. 2005. Corruption and the delivery of health and education services. In: Spector BI, (ed.). Fighting corruption in developing countries: strategies and analysis. Bloomfield, CT: Kumarian Press, pp. 181-212.
5. Balabanova D, McKee M. 2002a. Access to health care in a system transition: the case of Bulgaria. International Journal of Health Planning and Management 17: 377-95.
6. Balabanova D, McKee M. 2002b. Understanding informal payments for health care: the example of Bulgaria. Health Policy 62: 243-73.
7. Barber S, Bonnet F, Bekedam H. 2004. Formalizing under-the-table payments to control out-of-pocket hospital expenditures in Cambodia. Health Policy and Planning 19: 199-208.
8. Belli P, Shahriari H, Curtico Medical Group. 2002. Qualitative study on informal payments for health services in Georgia. HNP Discussion Paper. Washington, DC: World Bank.
9. Brinkerhoff DW. 2004. Accountability and health systems: Toward conceptual clarity and policy relevance. Health Policy and Planning 19: 371-9.
10. Brodwin PE. 1997. Politics, practical logic, and primary health care in rural Haiti. Medical Anthropology Quarterly 11: 69-88.
11. Chaudhury N, Hammer J. 2004. Ghost doctors: Absenteeism in Bangladeshi rural health facilities. The World Bank Economic Review 18: 423-41.
12. Cohen JC, Cercone JA, Macaya R. 2002. Improving transparency in pharmaceutical systems: strengthening critical decision points against corruption. Washington, DC: World Bank, Human Development Network, Latin American and Caribbean Region.
13. Di Tella R, Savedoff W. 2001. Diagnosis corruption: fraud in Latin America's public hospitals. Washington, DC: Inter-American Development Bank.
14. Dugger CW. 2006. Cambodia tries nonprofit path to health care. New York Times, January 8.
15. Duncan F. 2003. Corruption in the health sector. Washington, DC: USAID Bureau for Europe & Eurasia, Office of Democracy and Governance.
16. Eichler R, Auxila P, Pollack J. 2000. Performance based reimbursement to improve impact: evidence from Haiti. LAC Health Sector Reform Initiative, no. 44. Boston, MA: Management Sciences for Health.
17. Emerging Markets Group. 2005. Armenian reproductive health system review: structure and system inefficiencies that hinder access to care for rural populations. Washington, DC: Emerging Markets Group for USAID.
18. Ensor T. 2004. Informal payments for health care in transition economies. Social Science and Medicine 58: 237-46.
19. Ensor T, Antonio D-M. 2002. Corruption as a challenge to effective regulation in the health sector. In: Saltman RB, Busse R, Mossialos E, (eds). Regulating entrepreneurial behavior in European health care systems. Buckingham, UK: Open University Press.
20. Falkingham J. 2004. Poverty, out-of-pocket payments and access to health care: evidence from Tajikistan. Social Science and Medicine 58: 247-58.
21. Ferrinho P, Omar CM, de Jesus Fernandes M et al. 2004. Pilfering for survival: how health workers use access to drugs as a coping strategy. Human Resources for Health 2: 4.
22. Fung A, Graham M, Weil D. 2007. Full disclosure: the perils and promise of transparency. New York: Cambridge University Press.
23. Gaal P, McKee M. 2005. Fee-for-service or donation? Hungarian perspectives on informal payment for health care. Social Science and Medicine 60: 1445-57.
24. Garcia-Prado A, Chawla M. 2006. The impact of hospital management reforms on absenteeism in Costa Rica. Health Policy and Planning 21: 91-100.
25. Giedion U, Morales LG, Acosta OL. 2001. The impact of health reforms on irregularities in Bogota hospitals. In: Di Tella R, Savedoff WD, (eds). Diagnosis corruption: fraud in Latin America's public hospitals. Washington, DC: Inter-American Development Bank.
26. Gray-Molina G, Perez de Rada E, Yañez E. 2001. Does voice matter? Participation and controlling corruption in Bolivian hospitals. In: Di Tella R, Savedoff WD, (eds). Diagnosis corruption: fraud in Latin America's public hospitals. Washington, DC: Inter-American Development Bank.
27. Gupta S, Davoodi HR, Tiongson ER. 2002. Corruption and the provision of health care and education services. In: Abed GT, Gupta S, (eds). Governance, corruption, and economic performance. Washington, DC: International Monetary Fund, pp. 245-72.
28. Hessing DJ, Elffers H, Weigel RH. 1988. Exploring the limits of self-reports and reasoned action: an investigation of the psychology of tax evasion behavior. Journal of Personality and Social Psychology 54: 405-13.
29. Hotchkiss DR, Hutchinson PL, Malaj A, Berruti AA. 2004. Out-of-pocket payments and utilization of health care services in Albania: evidence from three districts. Bethesda, MD: Partners for Health Reformplus, Abt Associates Inc.
30. Jaen MH, Paravisini D. 2001. Wages, capture and penalities in Venezuela'. In: Di Tella R, Savedoff WD, (eds). Diagnosis corruption: fraud in Latin America's public hospitals. Washington, DC: Inter-American Development Bank, pp. 57-94.
31. Kassirer J. 2006. The corrupting influence of money in medicine. In: Transparency International. Global Corruption Report 2006: Special focus on corruption and health. London: Pluto Press.
32. Kaufmann D, Recanatini F, Biletsky S. 2002. Assessing governance: diagnostic tools and applied methods for capacity building and action learning. World Bank Institute discussion paper. Washington, DC: World Bank.
33. Khemani S. 2004. Local government accountability for service delivery in Nigeria. Washington, DC: World Bank.
34. Klitgaard R. 1988. Controlling corruption. Berkeley, CA: University of California Press.
35. Klitgaard R, Maclean-Abaroa R, Parris HL. 2000. Corrupt cities: a practical guide to cure and prevention. Oakland, CA and Washington, DC: Institute for Contemporary Studies and the World Bank Institute.
36. Krastev I. 2004. Shifting obsessions: three essays on the politics of anti-corruption. Budapest: Central European University Press.
37. Kurland NB. 1995. Ethical intentions and the theories of reasoned action and planned behavior. Journal of Applied Social Psychology 25: 297-313.
38. Kutzin J, Meimanaliev T, Ibraimova A et al. 2003. Formalizing informal payments in Kyrgyz hospitals: evidence from phased implementation of financing reforms. Paper presented at the 4th World Congress of the International Health Economics Association, San Francisco, CA.
39. Lantham S. 2001. Conflict of interest in medical practice. In: David M, Stark A, (eds). Conflict of interest in the professions. New York: Oxford University Press, pp. 279-301.
40. Lewis M. 2002. Informal health payments in central and eastern Europe and the former Soviet Union: issues, trends and policy implications. In: Mossialos M, Dixon A, Figueras J, Kutzin J, (eds). Funding health care: options for Europe. European Observatory on Health Care Systems Series. Buckingham, UK: Open University Press, pp. 184-205.
41. Lewis M. 2006. Governance and corruption in public health care systems. Working paper number 78. Washington, DC: Center for Global Development.
42. Lewis M. 2007. Informal payments and the financing of health care in developing and transition countries. Health Affairs 26: 984-97.
43. Lindelow M, Kushnarova I, Kaiser K. 2006. Measuring corruption in the health sector: What can we learn from public expenditure tracking and service delivery surveys in developing countries? In: Transparency International. Global Corruption Report 2006: Special focus on corruption and health. London: Pluto Press.
44. Management Sciences for Health. 2001. Using performance-based payments to improve health programs. The Manager 10.
45. McPake B, Asiimwe D, Mwesigye F et al. 1999. Informal economic activities of public health workers in Uganda: implications for quality and accessibility of care. Social Science and Medicine 49: 849-65.
46. Milewa T. 2006. Health technology adoption and the politics of governance in the UK. Social Science and Medicine 63: 3102-12.
47. Miller WL, Grodeland AB, Koshechkina TY. 2001. A culture of corruption? Coping with government in post-communist Europe. Budapest and New York: Central European University Press.
48. Mills AE, Edwards SM. 2001. Organizational Ethics or Compliance: Which will articulate values for the United States' healthcare system? HEC Forum 13: 329-43.
49. Office of Inspector General. 1998. OIG compliance program guidance for hospitals. Federal Register 63: 8987-98.
50. Olivier RW. 2004. What is transparency? New York: McGraw-Hill Companies: Inc.
51. Olivier de Sardan JP. 1999. A moral economy of corruption in Africa? The Journal of Modern African Studies 37: 25-52.
52. Raats MM, Shepherd R, Sparks P. 1995. Including moral dimensions of choice within the structure of the theory of planned behavior. Journal of Applied Social Psychology 25: 484-94.
53. Ramos M. 2003. Auditors' responsibility for fraud detection. Journal of Accountancy (online), January, p. 28, http://www.aicpa.org/pubs/jofa/ jan2003/ramos.htm.
54. Randall DM, Gibson AM. 1991. Ethical decision making in the medical profession-an application of the theory of planned behavior. Journal of Business Ethics 10: 111-22.
55. Reinikka R, Svensson J. 2002. Assessing frontline service delivery. Washington, DC: World Bank, Development Research Group, Public Services.
56. Rose R. 2006. Corruption is bad for your health: findings from Central and Eastern Europe. In: Transparency International. Global Corruption Report 2006: Special focus on corruption and health. London: Pluto Press, pp. 39-43.
57. Savedoff WD. 2006. The causes of corruption in the health sector: a focus on health care systems. In: Transparency International. Global Corruption Report 2006: Special focus on corruption and health. London: Pluto Press.
58. Schargrodsky E, Mera J, Weinschelbaum F. 2001. Transparency and accountability in Argentina's hospitals. In: Di Tella R, Savedoff WD, (eds). Diagnosis corruption: fraud in Latin America's public hospitals. Washington, DC: Inter-American Development Bank.
59. Segal G, Summers AB. 2002. Citizens' budget reports: improving performance and accountability in government. Reason Public Policy Institute, http://www.rppi.org/ps292.html, accessed 31 July 2007.
60. Soeters R, Griffiths F. 2003. Improving government health services through contract management: a case from Cambodia. Health Policy and Planning 19: 22-32.
61. Spector BI. 2005. Fighting corruption. Chapter 1. In: Spector B, (ed.). Fighting corruption in developing countries: strategies and analysis. Bloomfield, CT: Kumarian Press, pp. 1-9.
62. Tatar M, Ozgen H, Sahin B et al. 2007. Informal payments in the health sector: a case study from Turkey. Health Affairs 26: 1029-39.
63. Thompson DF. 2005. Restoring responsibility: ethics in government, business, and healthcare. New York: Cambridge University Press.
64. Transparency International. 2006. Global Corruption Report 2006: Special focus on corruption and health. London: Pluto Press.
65. Van Lerberghe W, Conceiçao C, van Damme W, Ferrinho P. 2002. When staff is underpaid: dealing with the individual coping strategies of health personnel. Bulletin of the World Health Organization 80: 581-4.
66. Vian T. 2003. Corruption in the health sector in Albania. USAID Corruption Reduction Project in Albania. Washington, DC: Management Systems International.
67. Vian T. 2006. Preventing drug diversion through supply chain management. U4 Brief 3. Bergen, Norway: Anti-Corruption Resource Centre, Chr. Michelsen Institute.
68. Vian T, Burak LJ. 2006. Beliefs about informal payments in Albania. Health Policy and Planning 21: 392-401.
69. Vian T, Collins D. 2006. Using financial performance indicators to promote transparency and accountability in health systems. U4 Brief 1. Bergen, Norway: Anti-Corruption Resource Centre, Chr. Michelsen Institute.
70. Vian T, Gryboski K, Sinoimeri Z, Hall R. 2006. Informal payments in government health facilities in Albania: results of a qualitative study. Social Science and Medicine 62: 877-87.
71. Waning B, Vian T. forthcoming. Transparency and accountability in an electronic era: the case of pharmaceutical procurement. U4 Brief. Bergen, Norway: Anti-Corruption Resource Centre, Chr. Michelsen Institute.
72. Werner C. 2000. Gifts, bribes and development in post-Soviet Kazakstan. Human Organization 59: 11-22.
73. Woodle D. 2000. Vaccine procurement and self-sufficiency in developing countries. Health Policy and Planning 15: 121-9.
74. World Bank. 2000. Helping countries combat corruption: progress at the World Bank since 1997. Washington, DC: World Bank.
75. World Bank. 2003. Poverty net tools and practices. Washington, DC: World Bank.
76. World Health Organization. 2006. Measuring transparency in medicines registration, selection and procurement: four country assessment studies. Geneva: World Health Organization.
77. World Health Organization. 2007. Measuring transparency to improve good governance in the public pharmaceutical sector: assessment instrument. Working document for field testing and revision. January 2007, rev. 1. Geneva: World Health Organization.